Canadian Journal of Infectious Diseases and Medical Microbiology

Canadian Journal of Infectious Diseases and Medical Microbiology / 2006 / Article

Editorial | Open Access

Volume 17 |Article ID 754986 | https://doi.org/10.1155/2006/754986

LE Nicolle, "Public Reporting: Illumination or Shadows?", Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 17, Article ID 754986, 2 pages, 2006. https://doi.org/10.1155/2006/754986

Public Reporting: Illumination or Shadows?

Abstract

The infection control communities in Britain and the United States (US) are experiencing an extraordinary conceptual shift with legislated mandatory reporting of hospital infections. In Britain, this shift began in 2001 with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia episodes (1), which are reported to the National Health Service and are publically available on a Health Protection Agency Web site. In the US, the impetus for public reporting of infection rates has come from consumer groups (2). These organizations have bypassed health care organizations and public health and other practitioners, and have addressed their demands to state legislatures. At least eight states have now passed and several more are considering legislation to mandate reporting. The process has been rancorous and, at least initially, vigorously opposed by health care organizations and infection control practitioners.

Copyright © 2006 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views35
Downloads168
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.